A $20 over-the-counter drug in Europe requires a prescription and $800 in the U.S.

What's new in pharma

October 31, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe Opinion: A $20 over-the-counter drug in Europe requires a prescription and $800 in the U.S. Pharma analyst David Maris examines the FDA process used by Bausch & Lomb to achieve a 40-fold price increase on a dry-eye drug. By David Maris STAT+ | Under Vinay Prasad, employees at a key FDA center fear speaking out, look for the exits Prasad, the hired-fired-rehired head of the Center for Biologics Evaluation and Research, rattles FDA staff by expanding power, pushing out senior leaders. By Lizzy Lawrence Health care takes center stage in this year's elections, a sign of midterm strategies to come In Virginia and New Jersey, both parties are reframing health care around costs and access, a test run for national strategy ahead of the 2026 midterms. By Daniel Payne Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser